Deepak Fertilisers delivered a record Q1 FY27 (Jun quarter): consolidated revenue +22% YoY to ₹3,256 cr, operating EBITDA +65% YoY to ₹845 cr (26% margin vs. 15–20% historical run-rate), and net profit more than doubled (+101% YoY, +252% QoQ) to ₹490 cr. The beat is almost entirely the Chemicals segment — TAN, nitric acid, ammonia — posting 43% segment margins; Fertilisers remains a thin, subsidy-linked ~3% business. DFPCL is increasingly a specialty / industrial chemicals story wrapped inside a legacy fertiliser company, and the next leg of the thesis is nearly here.
The setup — capex turns the corner in Q2 FY27
Two large expansions are 93–96% complete and slated to commission in Q2 FY27 (Sep quarter), ramping to ~80% utilisation by Q4 FY27:
| Project | Capacity / Type | Completion | Capex (₹ cr) | Of-take / Strategic |
|---|---|---|---|---|
| Gopalpur TAN expansion | 376 KTPA TAN (India's largest; >60% domestic share) | 96% (Q2 FY27 commission) | 2,675 | 20-yr offtake, Aarti Industries |
| Dahej nitric acid | 450 KTPA nitric acid (Asia's largest franchise) | 93% (Q2 FY27 commission) | 1,985 | Backed by Aarti offtake |
Combined, these take DFPCL to ~1 million tonnes of TAN capacity — India's largest, Asia's largest nitric acid franchise — with structural feedstock-cost relief from a May-2026 Equinor gas contract cutting ammonia cost ~25%. Management guides net debt / EBITDA (annualised Q1 FY27) improving from 2.86× to 1.4× — well below FY26-end 3.3× on trailing EBITDA — as capex ends and FCF turns positive from FY27.
Q1 FY27 momentum — the beat in one table
| Metric (₹ cr, unless %) | Q1 FY26 | Q1 FY27 | YoY | Comment |
|---|---|---|---|---|
| Consolidated Revenue | 2,659 | 3,256 | +22% | Record quarter; chemicals-led |
| EBITDA | 513 | 845 | +65% | Margin 26% vs 19% (+700bps) |
| EBITDA Margin | 19% | 26% | +700bps | Chemicals 43% seg. margin; fertiliser ~3% |
| Net Profit | 244 | 490 | +101% | +252% QoQ |
| Segment Margin — Chemicals | — | 43% | — | TAN / nitric / ammonia |
| Segment Margin — Fertilisers | — | ~3% | — | Subsidy-linked; thin |
Estimate check — FY26 actual vs Street (original)
| FY26 (₹ cr) | Original Est. | Actual | Variance | Note |
|---|---|---|---|---|
| Revenue | 10,823 | 11,506 | +6% | Volume + price mix |
| EBITDA | 2,020 | 1,684 | −17% | Capex-cycle drag; improving Q2+ |
| Net Profit | 841 | 739 | −12% | Still record; Q1 FY27 resets trajectory |
| EPS (₹) | 66.6 | 58.4 | −12% | Q1 FY27 run-rate above FY26 full |
The FY26 miss was capex-cycle (debt-funded expansions weighing). With commissions in Q2 FY27, EBITDA and net profit trajectory re-rate sharply — our ₹1,950 target applies a 12–21× forward P/E on FY27E, well below the 25–45× peer specialty-chemicals band, reflecting the valuation gap that the capex inflection and demerger should close.
Corporate action — the value-unlock the market hasn't priced in
DFPCL has already split into three legal entities — mining chemicals, industrial chemicals, crop nutrition — with a plan to demerge and separately list them over the next 2–3 years. The stock's current 12–21× forward P/E does not yet reflect this; comparable demerger / value-unlock precedents in Indian chemicals (e.g., Tata Chemicals, Gujarat Flourochemicals) have re-rated 30–60% on announcement. We treat the demerger as a positive-optional catalyst, not base-case.
Investment thesis — three pillars
Two expansions at 93–96% completion, 20-yr offtake with Aarti, Equinor gas cutting ammonia cost ~25%. Annualised Q1 EBITDA of ~₹3,380 cr implies FY27 EBITDA >₹3,000 cr — a ~80% lift over FY26.
Three-entity split → demerger + separate listing over 2–3 years. At 12–21× forward P/E vs 25–45× peers, even partial re-rating on announcement supports the ₹1,950 target.
From 2.86× (annualised Q1) / 3.3× FY26-end to ~1.4× as capex ends. Net debt / EBITDA below 1.5× removes the equity-market discount that has kept valuation compressed.
Equinor contract, TAN / nitric acid dominance (India's largest, Asia's largest), 43% segment margin vs legacy fertiliser ~3% — the mix-shift is permanent, not cyclical.
Valuation — where the target comes from
We derive the ₹1,950 target from FY27E EPS of ~₹107 (annualised from Q1 FY27 run-rate), applying 18× (mid-point of 12–21× band, conservative vs 25–45× peer range). A 12× multiple on the same EPS yields ₹1,284 (−15%, bear); 25× yields ₹2,675 (+78%, bull — requires demerger + full utilisation). We use the 18× midpoint to reflect partial demerger / utilisation assumption.
Catalysts (next 6–12 months)
| Timing | Catalyst / Event | Direction / Impact |
|---|---|---|
| Sep 2026 (Q2 FY27) | Gopalpur (376 KTPA) + Dahej (450 KTPA) commissioning; ramp to ~80% utilisation by Q4 FY27 | Positive — core thesis — EBITDA re-rate begins |
| Oct 2026 | Q2 FY27 results — first full quarter with both expansions commissioned | Positive — falsifier — OCF / FCF must turn positive |
| FY27–FY28 | Demerge / separate listing of 3 entities (mining chemicals / industrial chemicals / crop nutrition) | Positive-optional — 30–60% re-rating precedent |
| Rolling | Equinor gas contract — ammonia feedstock cost ~−25% (structural margin lift) | Positive — floor raises — not cyclical |
| FY27 | Net debt / EBITDA → ~1.4× (from 2.86× annualised Q1 / 3.3× FY26); FCF turns positive | Positive — equity discount removed |
Bear case — what could go wrong
The bear is execution / utilisation risk on new capacity, not demand. Key bear triggers: (1) Gopalpur / Dahej ramp slower than 80% by Q4 FY27 — EBITDA lift delayed; (2) subsidy / fertiliser-margin pressure (government price caps, input-subvention delays); (3) demerger deferred / cancelled — value-unlock option removed; (4) chemical-price cycle turns — TAN / nitric demand soft on global overcapacity. At ₹1,504 (14× FY27E), a bear-case 12× multiple on reduced FY27E EPS (~₹95) still supports ~₹1,140 (−24%), so downside is bounded by the capex-completion floor, not by structural failure.
Important disclosures
About this note
Prepared by Equinox Quantitative's quantitative equity-research team, 12 Aug 2026. Data sources: Deepak Fertilisers Q1 FY27 earnings release (Jun-26 quarter), company management commentary, NSE/BSE filings (DEEPAKFERT / 500645), Equinor gas-contract press reference (May 2026), Aarti Industries offtake agreement, and peer-valuation benchmarks (specialty-chemicals band 25–45× forward P/E). The GAIL FY26 Annual Deep-Dive reference document (PDF, 394 KB, downloaded 09 Aug 2026) was not extractable as machine-readable text (scanned / image-based); any GAIL references in this note are contextual only and should be verified against the original PDF at ../../07_📚_Documents/GAIL_FY26_AnnualReport_DeepDive_2026-08-09.pdf.
Appendix — company snapshot
| Item | Value |
|---|---|
| Full Name | Deepak Fertilisers and Petrochemicals Corporation |
| Ticker / Exchanges | NSE: DEEPAKFERT · BSE: 500645 · ISIN: INE501A01019 |
| Sector / Industry | Specialty & Industrial Chemicals / Fertilisers |
| CMP (11-Aug-26) | ₹1,504 |
| Rating / Price Target | OVERWEIGHT (Buy) / ₹1,950 (12M, +30%) |
| Market Cap (est. at CMP) | ~₹19,000 cr (approx.; depends on shares outstanding) |
| 52-Week Range | ₹866 (low) – ₹1,681 (high) |
| 1Y / 3Y / 10Y Price CAGR | +4% / +41% / multi-bagger (10Y) |
| Q1 FY27 Revenue (consol.) | ₹3,256 cr (+22% YoY) |
| Q1 FY27 EBITDA (margin) | ₹845 cr (26% vs 19% YoY) |
| Q1 FY27 Net Profit | ₹490 cr (+101% YoY, +252% QoQ) |
| Capex (Gopalpur + Dahej) | ₹4,660 cr (2,675 + 1,985) |
| Net Debt / EBITDA (annualised Q1) | ~1.4× (down from 2.86× / 3.3× FY26) |
| Demerge Plan | 3 entities (mining chemicals / industrial chemicals / crop nutrition) — 2–3 yrs |
| Key Of-take | Aarti Industries (20-yr) — TAN + nitric acid |
Prepared by Equinox Quantitative. Independent equity-research initiation on Deepak Fertilisers (NSE: DEEPAKFERT · BSE: 500645) — 12 Aug 2026. Rating OVERWEIGHT; 12-month price target ₹1,950 (+30%). Source material: Q1 FY27 earnings release, company commentary, filings, Equinor gas-contract reference. Not investment advice. See Important Disclosures above. Brand identity: deep navy #0a1628, off-white #f0ede4, mute slate #8b95a7, gold #c9a961.